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Abstract
Colorectal cancer (CRC) screening is underutilized, especially in low income, high minority
populations. We examined the effect test-specific barriers have on colonoscopy and fecal
immunochemical test (FIT) completion, what rationales are given for non-completion, and what
“switch” patterns exist when participants are allowed to switch from one test to another. Low
income adults who were not up-to-date with CRC screening guidelines were recruited from safety-
net clinics and offered colonoscopy or FIT (n=418). Follow up telephone surveys assessed test-
specific barriers. Test completion was determined from patient medical records. For subjects who
desired colonoscopy at baseline, finding a time to come in and transportation applied more to non-
completers than completers (p = 0.001 and p < 0.001, respectively). For participants who initially
wanted FIT, keeping track of cards, never putting stool on cards, and not remembering to mail
cards back applied more to non-completers than completers (p = 0.003, p = 0.006, and p < 0.001,
respectively). The most common rationale given for not completing screening was a desire for the
other screening modality: 7% of patients who initially preferred screening by FIT completed
colonoscopy, while 8% of patients who initially preferred screening by colonoscopy completed
FIT. We conclude that test-specific barriers apply more to subjects who did not complete CRC
screening. As a common rationale for test non-completion is a desire to receive a different
screening modality, our findings suggest screening rates could be increased by giving patients the
opportunity to switch tests after an initial choice is made.
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Colorectal cancer is the third leading cause of cancer related deaths in the United States,
accounting for nearly 11% of all cancer mortality [1]. Colorectal cancer screening is
effective in lowering the incidence and mortality rates of this disease [2, 3]. The U.S.
Preventive Services Task Force (USPSTF), the American Cancer Society, the US Multi-
Society Task Force on Colorectal Cancer, and the American College of Radiology agree
routine screening for average risk individuals should begin at the age of 50 and end at 75 [4,
5]. A variety of screening methods are recommended: fecal blood test (fecal occult blood
test, FOBT, or fecal immunochemical test, FIT) annually, flexible sigmoidoscopy or double
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contrast barium enema (DCBE) every five years, or colonoscopy every 10 years [4, 5].
However, screening remains underutilized in the United States, with only 54.2% of age-
eligible adults up-to-date with current guidelines [6].
Due to the benefits that may be achieved by screening and its current underutilization, it is
important to understand what factors predict screening adherence and what methods can be
used to overcome barriers to, or facilitate completion of, screening. Factors previously
associated with screening adherence include age [7-9], gender [10-14], education level
[15-18], race/ethnicity [9, 12, 16, 19], income [8, 12, 20], marital status [9, 21-23], fatalistic
beliefs about cancer [24-26], and knowledge [8, 24, 27, 28] and fear [12, 24, 27-30] of
screening tests. Other factors such as physician involvement [8, 9, 21, 23, 31-33], access to
health care [13, 14, 19, 34, 35], geographic location [9, 21, 36], and test-specific barriers
[12, 23, 27, 37-40] have also been found to influence screening adherence.
Although colorectal cancer screening predictors, barriers, and facilitators in low income and
minority populations have been studied extensively, they are not currently well understood.
Past studies have analyzed these populations’ perceived barriers to colorectal cancer
screening through surveys and focus groups [12, 24, 26, 27, 41, 42]. The present study takes
the next step, and correlates these findings with actual test adherence. Specifically, we
analyzed the effect certain test-specific barriers have on colonoscopy and FIT completion,
what rationales are given by individuals who choose not to complete screening, what
screening modality (colonoscopy or FIT) seemed most desirable in a low income, high
minority population, and finally what “switch” patterns seemed to emerge when screening
eligible individuals were given the option to switch from one test to the other (colonoscopy
or FIT) over a 6 month period of time.
METHODS
Study Design
This study and all protocols were approved by the University of Kansas Medical Center
Human Subjects Committee. Written informed consent was obtained from all study
participants.
Study staff recruited 470 study participants in eight Kansas City safety net clinics on a
rotating basis between September 2008 and May 2010. Patients in each clinic’s waiting
room were informed of the study by project staff, and those who were interested were
subsequently screened for inclusion requirements. Those who met study eligibility
requirements were directed to a touchscreen computer kiosk to complete a survey and
receive culturally tailored education and information regarding colorectal cancer screening.
Computers were equipped with headphones, and a narrator read survey questions and
provided educational information to accompany graphics in each participant’s preferred
language (English or Spanish).
At the end of each computer session participants were offered the choice of a no cost
screening test with either FIT or colonoscopy (Figure 1). Those preferring FIT were given a
pre-packaged kit containing stool cards, applicator brushes, and a pre-addressed lab-return
envelope. Those preferring a colonoscopy received a colonoscopy scheduling instruction
card. The instruction card contained a phone number to call for scheduling, a blank line to
write in the date and time of a future test, and the name of the University of Kansas Medical
Center (KUMC) endoscopy lab. In some cases (<5%), study staff assisted participants in
making an initial call for scheduling a colonoscopy. All testing and laboratory procedures
were provided at no financial cost to participants.
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To be included in the study, participants had to have a household income of less than 150%
of the Federal Poverty Level (FPL). Participants were required to be 50 years of age or
above and not up-to-date with current U.S. Preventive Services Task Force screening
guideline recommendations. Individuals with an acute medical illness, current
gastrointestinal bleeding, a history of adenomatous polyps, colorectal cancer, an inherited
polyposis/non-polyposis syndrome, a first degree relative with colorectal cancer prior to age
60, or inflammatory bowel disease were excluded. While no formal assessment of dementia
or psychiatric illness was performed, any participant demonstrating impaired cognitive
function or inappropriate affect or behavior was also excluded. Additionally, only one
member from a single household was allowed to enroll in the study.
Follow Up
No contact was made with participants until follow up phone calls began 90 days after
subject enrollment. At 90 days, participants were contacted to complete a standardized
telephone survey conducted by study staff. The survey asked about self-reported test
completion and assessed barriers subjects may have encountered with either colonoscopy or
FIT (Figures 2 and 3). Questions addressing barriers asked participants to respond to a four
point Likert scale. Answers ranged from: 1-does not apply at all, 2-applies a little, 3-applies
somewhat, and 4-applies very much. Additionally, for those not completing their chosen test
(colonoscopy or FIT) at 90 days, comments were gathered on why they did not complete
screening. If participants stated they still planned to complete a test, they were given the
option to “switch” from colonoscopy to FIT or vice versa. These participants were also
scheduled for another follow up phone survey in the future.
While self-reported data on test adherence was obtained, the primary method for measuring
test completion adherence was by receipt of mailed and correctly completed FIT cards or
receipt of an endoscopy test at KUMC. FIT cards were processed by certified laboratory
personnel at Quest Diagnostics Laboratories (Lenexa, KS) with results electronically
transmitted to project staff. Medical record data on completed colonoscopies was obtained
from the endoscopy lab at KUMC.
Analysis
Quantitative Likert scale data were used to investigate whether FIT or colonoscopy-specific
barriers applied more for those who did not complete their initially chosen screening test as
compared to those who did complete their initially chosen screening test. For each barrier
question, an answer of 3 or 4 was counted as a negative response and an answer of 1 or 2
was counted as a positive response. Frequencies of negative and positive responses were
compared between completers and non-completers for each barrier. Chi-square tests were
used to determine if any of these differences were significant. When expected frequencies
fell below five, two-sided Fisher’s exact tests were used. Because multiple barriers were
assessed simultaneously, the Bonferroni correction was used to maintain an overall p = 0.05.
Qualitative data from participant comments made during phone surveys was used to analyze
reasons given for non-adherence for those who initially chose a colonoscopy or FIT at
baseline but did not follow through with their preferred test. During follow up, non-
completers who initially intended to complete either a colonoscopy or FIT at baseline were
asked why they had not completed the respective test. Responses were categorized into
common themes such as problems with “scheduling” or “transportation.” Response
frequencies were used to discern the main reasons for not completing either a colonoscopy
or FIT.
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Demographic characteristics of study participants are shown in Table 1. This study was only
concerned with the test completion status of those participants who preferred screening at
baseline. Because of this, the subject characteristics in Table 1 do not include the 52 people
who initially “preferred no test.” Those included in analysis (N=418) are indicated by the
shaded area in Figure 1.
The median age of participants was 55.0 years with a majority of subjects falling below the
age of 60 (74.4%). Nearly two thirds of the study participants were female and over 75%
had no health insurance (77.3%). The most represented race/ethnicity was non-Hispanic
African Americans (42.8%), however, there was considerable representation of non-
Hispanic Whites (28.9%) and Hispanics (25.6%). One third of the participants were
currently married (32.5%) and there were varying levels of educational attainment, although
there was a slight tendency towards less education.
Colonoscopy-Specific Barriers
For those subjects who initially wanted a colonoscopy at baseline (N = 251), problems
finding a time to come in (p = 0.001) and problems getting to and from an appointment (p <
0.001) applied more to non-completers than completers (Figure 2). Interestingly, the
completers’ response rate for answering barrier questions was higher than the non-
completers’ response rate; 91 of 96 completers (94.8%) and 75 of 155 non-completers
(48.4%) gave responses.
FIT-Specific Barriers
For those subjects who initially wanted an FIT at baseline (N = 167), problems keeping
track of cards (p = 0.003), never getting around to putting stool on cards (p = 0.006), and not
remembering to mail cards back (p < 0.001) applied more to non-completers than
completers (Figure 3). Again, the completers’ response rate for answering barrier questions
was higher than the non-completers’ response rate; 80 of 85 completers (94.1%) and 34 of
82 non-completers (41.5%) gave responses.
Reasons Given for Non-Adherence
A variety of responses were given by colonoscopy non-completers (N = 97, 62.6% response
rate) with regard to their non-adherence (defined as those subjects who did not complete the
screening test they preferred at baseline), such as: the desire for completing an FIT instead
(39.2%), scheduling problems (34.0%), transportation problems (11.3%), health reasons
(9.3%), and being too busy (8.2%) (Note that participants were allowed to respond with
more than one rationale).
Fewer reasons (N = 40, 48.8% response rate) were given for FIT non-adherence. However,
fewer subjects preferred FIT at baseline (167 FIT vs. 251 colonoscopy) and the FIT non-
completer response rate was lower (48.8% vs. 62.6%). The most common rationales given
for FIT non-adherence were the desire for completing a colonoscopy instead (35.0%), self-
reported FIT completion with no results having been reported to study staff by Quest
Laboratories (32.5%), and lost FIT kit (20.0%).
Test Preference and Completion Rates
Colonoscopy was the most preferred test at baseline when compared to FIT (251 vs. 167
subjects). However, only 38.2% (96 out of 251 subjects) of those who initially wanted a
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colonoscopy received one compared to 50.9% (85 out of 167) who initially wanted an FIT.
Overall, 107 subjects received screening by colonoscopy and 105 by FIT. Eleven subjects
who initially wanted an FIT completed screening by a colonoscopy instead, while 20
subjects who initially wanted a colonoscopy completed screening by an FIT instead (Table
2).
DISCUSSION
When comparing completers and non-completers for those who initially wanted a
colonoscopy at baseline, non-completers tended to have more issues with scheduling a
colonoscopy (p = 0.001) and finding transportation (p < 0.001). Problems with scheduling
and transportation were specifically reported by participants as rationales for colonoscopy
non-adherence (34.0% and 11.3% of subjects, respectively). The majority of problems
reported with scheduling were due to subjects never reaching anyone at the endoscopy
clinic, leaving messages and not receiving return calls, or being placed on hold so long that
they gave up. It is unclear if completers faced these same barriers but persevered or if they
were simply lucky enough to reach someone on their first attempt when scheduling an
appointment. Regardless, it seems reasonable that a more effective system for endoscopy
scheduling would increase colorectal cancer screening by colonoscopy. Transportation was
commonly reported as an issue for subjects who depended on someone else for a ride.
Additionally, some noted they would be able to get to the appointment but not back home.
Further research is needed on how to overcome issues with transportation.
While many focus groups and surveys suggest fear of embarrassment, pain, and injury are
perceived barriers to obtaining a colonoscopy [12, 23, 27, 37-40], this report did not find any
of these factors to be significantly linked with non-adherence. However, barriers regarding
fear of pain (p = 0.013) and injury (p = 0.027) did appear to affect non-completers more than
completers, although these findings were not significant after adjusting for multiple
comparisons (threshold p ≤ 0.005).
When comparing completers and non-completers among those who initially wanted an FIT
at baseline, non-completers tended to have more problems keeping track of cards (p =
0.003), never getting around to putting stool on cards (p = 0.006), and not remembering to
mail cards back (p < 0.001). Nearly 30% of rationales given for FIT non-adherence involved
subjects losing FIT kits or being too busy or forgetful to complete the test. Interventions in
the literature suggest that patient mailings [43, 44], telephone outreach [45, 46], and patient
navigators [47, 48] can all increase colorectal cancer screening rates. However, none of
these studies evaluated the effect of these interventions on FIT screening alone. Perhaps one
or a mix of these methods could be used to remind patients to complete testing via FIT. This
type of outreach could also provide information on how to obtain extra FIT kits for patients
who have lost theirs.
A large number of participants self-reported completion of FIT while their medical records
reflected non-adherence (32.5%). This could be due to reporting bias. It could also reflect a
high number of cards received by Quest that were prepared incorrectly or had been damaged
in the mail. In this scenario, subjects who mailed the cards might automatically assume their
FIT test was able to be processed. With FIT, patients may assume that no news is good news
and develop a false sense of confidence that their tests have been received, processed, and
found to contain no occult blood. While it is possible that some participants completed an
FIT outside of the study, this is unlikely since the additional cost and effort would have been
prohibitive. Future studies may be necessary to insure that informatics systems are in place
to follow up with patients who incorrectly prepare a FIT test at home. Practice systems will
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need mechanisms to arrange re-testing and possibly education to maximize proper sample
collection and submission by patients.
Out of the 418 study participants, 251 (60.0%) initially preferred colonoscopy while 167
(40.0%) initially preferred FIT. Adherence to baseline screening preference was 38.2% (96
out of 251) for colonoscopy and 50.9% (85 out of 167) for FIT. In addition, 11 subjects who
preferred FIT at baseline completed screening with a colonoscopy and 20 subjects who
preferred a colonoscopy at baseline completed screening with an FIT. Overall, 106 (25.4%)
subjects completed screening by colonoscopy and 105 (25.1%) by FIT for an overall
completion rate of 55.5%. Thus, while colonoscopy was the most preferred test at baseline,
follow up suggests the completion rates for both screening methods are similar in this
population.
Because a number of subjects (6-8%) completed screening by a different method than their
stated baseline preference, it appears that having the option and knowledge of how to switch
tests is important. At baseline, study participants were mostly only given information about
their preferred screening test. Switching screening modalities required extra effort by study
participants. Many of the subjects switching from colonoscopy to FIT first stated they were
interested in a switch when they were contacted for the follow up survey. In contrast, those
wishing to switch from FIT to colonoscopy would have had to call the endoscopy lab to
schedule an appointment. Perhaps if screening information for both tests was made available
to participants throughout the intervention more subjects might have switched and
completed screening, rather than giving up because they decided their preferred screening
method was undesirable. Indeed, research suggests that only 40% of patients referred for a
colonoscopy are even aware of alternative screening options [37]. Future research is needed
to determine whether screening rates could be increased by enabling patients to switch tests
after an initial choice is made.
The present study has several strengths and limitations. While survey response rates were
high for those completing testing, those who did not complete testing tended to have low
response rates. This is most likely due to non-responders lack of time, interest, or motivation
to participate in the study. Non-completer response rates for the quantitative colonoscopy
and FIT barrier data shown in figures 2 and 3 were 48.4% and 42.9%, respectively.
Response rates for giving non-adherence rationales for colonoscopy or FIT were 62.6% and
48.8%, respectively. Lower response rates could bias the results if responders held different
views than non-responders.
It is also important to note that all information and screening was provided at no financial
cost to study participants. This allows for the evaluation of barriers which become
significant in the absence of monetary burdens. It is becoming increasingly important to
understand these barriers as the Affordable Care Act is estimated to insure an additional 34
million Americans by 2019 [49, 50]. A strength of this study is its high degree of
generalizability to those seeking care at safety net clinics, as a large and diverse group of
safety net clinics was included in subject recruitment. However, caution must be used when
extending these findings to other primary care clinics in the United States as well as other
low income, high minority populations who do not use safety net clinics, as the behaviors
influencing colorectal cancer screening may differ from the study population. To our
knowledge, this is the first study to show test switching as a common rational given for not
completing a colonoscopy or FIT. The fact that information on barriers and facilitators to
screening was linked with actual test adherence determined by medical records also made
this study unique.
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Figure 1. Study Diagram
Shaded area represents participants included in data analysis (N=418).
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Figure 2. Comparison of Completers and Non-Completers Negative Responses to Colonoscopy
Barrier Questions
91 of 96 completers (94.8%) and 75 of 155 non-completers (48.4%) gave responses.
*Statistically significant difference (Bonferroni’s procedure for controlling 5% type I error
rate).
†A= Problems finding a time you can come in; B= Not liking the large amount of fluid and
laxative you have to drink; C= Discomfort from going to the bathroom 10-15 times to clear
out the colon; D= Fear of pain; E= Fear of embarrassment; F= Fear of injury to colon; G=
Unwilling to have a tube inserted in rectum; H= Too much of an invasion of personal
privacy; I= Fear that the test results would show something bad; J= Problems getting to and
from appointment.
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Figure 3. Comparison of Completers and Non-Completers Negative Responses to FIT Barrier
Questions
80 of 85 completers (94.1%) and 34 of 82 non-completers (41.5%) gave responses.
*Statistically significant difference (Bonferroni’s procedure for controlling 5% type I error
rate).
†K= Problems keeping track of the cards; L= Never getting around to putting the stool on
the cards; M= Disgusted by the idea of putting stool and water on the cards; N= Worry
about germs or contamination from stool; O= Not remembering to mail the cards back; P=
Takes too long to get the test results; Q= Doubt that the test results would be correct or
accurate; R= Fear that the test results would show something bad.
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Table 1
Subject Characteristics (N = 418)
Characteristic Value
Age, median (Interquartile Range) 55.0 (52.0-60.0)
Age group, N (%)
 50-59* 311 (74.4)
 60-69 95 (22.7)
 70-79 12 (2.9)
Sex, N (%)
 Male 152 (36.4)
 Female 266 (63.6)
Race/Ethnicity, N (%)
 Hispanic 107 (25.6)
 Non-Hispanic White 121 (28.9)
 Non-Hispanic Black 179 (42.8)
 Non-Hispanic Other 11 (2.6)
Marital Status, N (%)
 Married or Living w/ Partner 136 (32.5)
 Divorced or Separated 153 (36.6)
 Widowed/never married/other 129 (30.9)
Education Level, N (%)
 Some high school and below 136 (32.5)
 High school grad/GED 108 (25.8)
 Some college or tech school 118 (28.2)
 College grad and above 56 (13.4)
Insurance, N (%)
 Yes 95 (22.7)
 No 323 (77.3)
*
1 subject was 49 at enrollment
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Table 2




Percent of Subjects who
Switched and Completed (%)†
FIT (N=167) 11 6.6
Colonoscopy (N=251) 20 8.0
Total (N=418) 31 7.4
*
Subjects who completed screening by the test opposite of their initial preference (i.e., 11 who initially preferred FIT completed screening by
colonoscopy).
†
By initial test preference (i.e., if initial test was FIT, 11/167 = 6.6%).
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